Frontiers in psychiatrySep 25, 2026

How gut microbes may influence postpartum depression and treatment possibilities

Gut-Brain Axis Weekly Brief ↗PubMed ↗DOI ↗OA ↗

Updated Sep 26, 2026

Abstract

Postpartum depression (PPD) affects 10-15% of mothers and is linked to gut microbiota alterations.

Alterations in gut microbiota may disrupt the gut-brain axis, which is associated with the development of PPD.
Microbial metabolite signaling, immune-inflammatory responses, and neuroendocrine disruptors are potential mechanisms involved in PPD.
Microbial-targeting approaches, such as probiotics and dietary changes, could offer therapeutic potential for restoring microbial health in PPD.
Current evidence primarily comes from cross-sectional studies, indicating a need for well-designed longitudinal human research to establish causal links.
Existing microbiota-related interventions have yet to evolve into precise microbiome therapeutics, highlighting significant translational uncertainties.

Simplified

Postpartum depression (PPD), a common but mechanistically uncertain mood disorder, occurs in 10-15% of mothers and seriously affects maternal and infant health. Recent evidence suggests that alteration of gut microbiota could dysregulate gut-brain axis functioning, which is potentially linked to the pathogenesis of PPD. This review innovatively synthesizes up-to-date preclinical and clinical evidence to illustrate relevant mechanisms, including microbial metabolite signaling, immune-inflammatory pathways, and neuroendocrine disruptors. Furthermore, the therapeutic potential of microbial-targeting approaches, including probiotics, dietary changes, and fecal microbiota transplant, to remedy PPD by restoring microbial health is discussed. Nevertheless, several notable limitations, translational uncertainties and major knowledge gaps still exist in this field. Most current evidence derives from cross-sectional observations, and well-designed longitudinal human studies are urgently needed to confirm causal relationships. In addition, available microbiota-related interventions have not yet developed into mature precision microbiome therapeutics. Against this background, this study proposes a microbiome framework connecting basic science and clinical applications that may help unravel the etiology and treatment of PPD.

Full Text

Full text is available at the source.

View Full Text ↗

Featured in

Gut-Brain AxisIssue #56

A gut infection in newborn mice caused memory problems that lasted into adulthood

↗

How gut microbes may influence postpartum depression and treatment possibilities

Abstract

Full Text

Featured in

You found one interesting study. We’ll send the next 7.

What Lands in Your Inbox Each Week:

Recent issues from the gut-brain axis brief